ARS Pharmaceuticals
NASDAQ: SPRYSan Diego, US · Founded 2015 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
JL
Jonathan LeffDirector
RL
Richard LowenthalExecutive Officer, Director
PS
Pratik ShahDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$55MraisedSep 2021 · 8 investors · PharmaceuticalsRule 506(b)
▶$55MraisedSep 2021 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rajeev DadooDirector
- Peter KolchinskyDirector
- Mike KellyDirector
- Brent SaundersDirector
- Richard LowenthalExecutive Officer, Director
- Dana McGowanExecutive Officer
- Pratik ShahDirector
- Jonathan LeffDirector
- Phil SchneiderDirector
- Offering amount
- $55M
- Amount sold
- $55M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedOct 2018 · 2 investors · PharmaceuticalsRule 506(b)
▶$8MraisedOct 2018 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan LeffDirector
- Richard LowenthalExecutive Officer, Director
- Pratik ShahDirector
- Offering amount
- $20M
- Amount sold
- $8M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.